Combined DNA vaccines formulated either in DDA or in saline protect cattle from Mycobacterium bovis infection (Q46510361)

22 December 2017

title

Combined DNA vaccines formulated either in DDA or in saline protect cattle from Mycobacterium bovis infection (English)

1 reference

22 December 2017

1 reference

Cai H

1

1 reference

22 December 2017

Tian X

2

1 reference

22 December 2017

Hu XD

3

1 reference

22 December 2017

Li SX

4

1 reference

22 December 2017

Yu DH

5

1 reference

22 December 2017

Zhu YX

6

1 reference

22 December 2017

language of work or name

English

0 references

publication date

14 April 2005

1 reference

22 December 2017

number of pages

9

1 reference

inferred from page(s)

published in

Vaccine

1 reference

22 December 2017

volume

23

1 reference

22 December 2017

issue

30

1 reference

22 December 2017

page(s)

3887-3895

1 reference

22 December 2017

Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

A review of M. bovis BCG protection against TB in cattle and other animals species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Protection against tuberculosis by a plasmid DNA vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

The immunogenicity of single and combination DNA vaccines against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Therapy of tuberculosis in mice by DNA vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Recognition of a common mycobacterial T-cell epitope in MPB59 of Mycobacterium bovis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Bovine tuberculosis: immune responses in the peripheral blood and at the site of active disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Protection of mice with a divalent tuberculosis DNA vaccine encoding antigens Ag85B and MPT64.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Combined DNA vaccines formulated in DDA enhance protective immunity against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Immunogenicity and protective efficacy study using combination of four tuberculosis DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Vaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Vaccination of mice and cattle with plasmid DNA encoding the Mycobacterium bovis antigen MPB83.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

Cloning and B-cell-epitope mapping of MPT64 from Mycobacterium tuberculosis H37Rv

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

7 January 2021

inferred from DOI database lookup

Mapping of the delayed-type hypersensitivity-inducing epitope of secreted protein MPT64 from Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

7 January 2021

inferred from DOI database lookup

Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.025

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VACCINE.2005.03.025

1 reference

22 December 2017

PubMed ID

15917109

1 reference

22 December 2017